Coronary interventions Clinical outcomes of long stent in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry Kong MG, Han J-K, Kang J, Zheng C, Yang H, Park K, Kang H-J, Koo B, Chae I, Kim H, Choi YJ, Shin E, Bae J-W, Chun K-J, Kim D, Rha S, Lee S, Rhew JY, Woo S-I, Lee HC, Jeong J-O September 24, 2019 | 10.4244/EIJ-D-19-00296
Stents and scaffolds Long-term safety of bioresorbable scaffolds: insights from a network meta-analysis including 91 trials Kang S, Gogas B, Jeon K, Park J-S, Lee W, Yoon C, Suh J-W, Hwang S-S, Youn T, Chae I, Kim H March 20, 2018 | 10.4244/EIJ-D-17-00646
Coronary interventions Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial Kang S, Chung W-Y, Lee J, Park J-J, Yoon C, Suh J-W, Cho Y-S, Doh J, Cho J, Bae J-W, Youn T, Chae I January 20, 2017 | 10.4244/EIJ-D-16-00179
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019